With the wide application of immune checkpoint inhibitors(ICIs)in the field of tumor treatment,a series of immune-related adverse reactions of cardiovascular system caused by ICIs have aroused clinicians'attention.ICIs-associated myocarditis has become a focus due to its relatively low incidence but high lethality.At present,we have not known enough about the molecular mechanism and pathophysiological process of ICIs-induced myocarditis.This paper explores the pathological mechanisms of ICIs-associated myocarditis,its risk factors,clinical features,means of diagnosis and monitoring,and formulation of reasonable treatment strategies through literature review,so as to enhance clinicians'alertness and ability to deal with such adverse events,and improve the prognosis of tumor patients.
维普
万方数据